You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rifaximin

Showing 1 - 25 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn Disease, Diabetic Gastroparesis Trial in Jacksonville (Rifaximin, Placebo)

Recruiting
  • Crohn Disease
  • Diabetic Gastroparesis
  • Rifaximin
  • Placebo
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 12, 2022

Healthy Volunteers, Stress, Fear Trial in Leuven (Rifaximin, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • +2 more
  • Rifaximin
  • Placebo
  • Leuven, Belgium
    UZ/KU Leuven
Oct 17, 2022

Severe Hepatic Impairment Trial in San Antonio (Rifaximin)

Recruiting
  • Severe Hepatic Impairment
  • Rifaximin
  • San Antonio, Texas
    Valeant Site 01
Sep 7, 2022

Liver Cirrhosis, Renal Failure Trial in New York (Rifaximin, Lactulose)

Withdrawn
  • Liver Cirrhosis
  • Renal Failure
  • New York, New York
    Weill Cornell Medical Center
Jan 24, 2022

Small Intestinal Bacterial Overgrowth, Liver Cirrhosis Trial in Mexico (Rifaximin, Placebo)

Terminated
  • Small Intestinal Bacterial Overgrowth
  • Liver Cirrhosis
  • Rifaximin
  • Placebo
  • Mexico, Ciudad De Mexico, Mexico
    Centro Médico Nacional Siglo XXI
Mar 7, 2022

Crohn's Disease Trial in Seattle (Placebo Comparator, Rifaximin)

Completed
  • Crohn's Disease
  • Placebo Comparator
  • Rifaximin
  • Seattle, Washington
    University of Washington Medical Center
Dec 1, 2021

Microbial Colonization Trial in Atlanta (Rifaximin)

Completed
  • Microbial Colonization
  • Rifaximin
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Oct 8, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Best Practice
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 5, 2023

Chronic Kidney Disease Trial in Kansas City (Rifaximin, Placebo)

Completed
Has Results
  • Chronic Kidney Disease
  • Rifaximin
  • Placebo
  • Kansas City, Kansas
    University of Kansas Medical Center
Oct 8, 2021

Visceral Hypersensitivity, Irritable Bowel Syndrome Trial in Los Angeles (Rifaximin)

Terminated
  • Visceral Hypersensitivity
  • Irritable Bowel Syndrome
  • Rifaximin
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 19, 2021

Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth Trial in Girona (Probiotic, Rifaximin)

Terminated
  • Irritable Bowel Syndrome
  • Small Intestinal Bacterial Overgrowth
  • Probiotic
  • Rifaximin
  • Girona, Spain
    Dr. Bofill Clinic
Nov 2, 2022

Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea Trial in Ann Arbor (Rifaximin, Glucose and lactulose hydrogen

Recruiting
  • Irritable Bowel Syndrome
  • Irritable Bowel Syndrome With Diarrhea
  • Rifaximin
  • Glucose and lactulose hydrogen breath testing
  • Ann Arbor, Michigan
    University of Michigan
Dec 1, 2021

IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

Recruiting
  • IgA Monoclonal Gammopathy
  • +8 more
  • Rifaximin
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 18, 2021

Clostridium Difficile Infection Trial in Nottingham (Rifaximin, Placebo)

Completed
  • Clostridium Difficile Infection
  • Rifaximin
  • Placebo
  • Nottingham, Nottinghamshire, United Kingdom
    Nottingham Clinical Trials Unit (NCTU), Queen's Medical Centre
Oct 5, 2021

Cirrhosis, Liver, Minimal Hepatic Encephalopathy, Small Intestinal Bacterial Overgrowth Trial in Cleveland (Rifaximin)

Recruiting
  • Cirrhosis, Liver
  • +3 more
  • Rifaximin
  • Cleveland, Ohio
    Metrohealth Medical Center
Nov 23, 2021

Irritable Bowel Syndrome Trial in Shanghai (Rifaximin, Fecal microbiota transplantation)

Recruiting
  • Irritable Bowel Syndrome
  • Rifaximin
  • Fecal microbiota transplantation
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Dec 29, 2021

Irritable Bowel Syndrome With Diarrhea Trial in Los Angeles (Rifaximin, N-acetylcysteine, Placebo)

Active, not recruiting
  • Irritable Bowel Syndrome With Diarrhea
  • Rifaximin
  • +2 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 3, 2021

Cirrhosis, Ascites, Peritonitis Trial in France (Rifaximin, Placebo)

Active, not recruiting
  • Cirrhosis
  • +2 more
  • Rifaximin
  • Placebo
  • Amiens, France
  • +17 more
Jul 12, 2022

Covert Hepatic Encephalopathy Trial in Shanghai (Rifaximin)

Completed
  • Covert Hepatic Encephalopathy
  • Rifaximin
  • Shanghai, Shanghai, China
    Shanghai changzheng Hospital
Jun 28, 2021

Parkinson Disease Trial in San Francisco (Rifaximin, Placebo)

Recruiting
  • Parkinson Disease
  • Rifaximin
  • Placebo
  • San Francisco, California
    University of California San Francisco
Oct 25, 2022

Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth Trial in Kuala Lumpur (Rifaximin, Low FODMAP diet)

Recruiting
  • Irritable Bowel Syndrome
  • Small Intestinal Bacterial Overgrowth
  • Rifaximin
  • Low FODMAP diet
  • Kuala Lumpur, Malaysia
    University Malaya Medical Centre
May 4, 2021

Hepatic Encephalopathy Trial (Rifaximin)

Completed
  • Hepatic Encephalopathy
  • Rifaximin
  • (no location specified)
Feb 1, 2021

Liver Cirrhosis, Chronic Hepatitis C Trial in Philadelphia (Rifaximin, Placebo)

Terminated
  • Liver Cirrhosis
  • Chronic Hepatitis C
  • Rifaximin
  • Placebo
  • Philadelphia, Pennsylvania
    Philadelphia VA Medical Center
Mar 8, 2021

Spontaneous Bacterial Peritonitis Trial in Foggia (Rifaximin, Norfloxacin)

Active, not recruiting
  • Spontaneous Bacterial Peritonitis
  • Foggia, Italy
    Ospedali Riuniti Foggia
Feb 15, 2021

Small Intestinal Bacterial Overgrowth Trial in Woolloongabba, Lucknow (device, diagnostic test, procedure, drug)

Recruiting
  • Small Intestinal Bacterial Overgrowth
  • Atmo Gas Capsule
  • +5 more
  • Woolloongabba, Queensland, Australia
  • +1 more
Jul 19, 2022